| | 347396-82-1 Basic information More.. |
| Product Name: | Ranibizumab | | Synonyms: | Lucentis;Ranibizumab;Unii-zl1R02vt79;Ranibizumab - 25mg/ml solution in PBS;Ranibizumab USP/EP/BP;RanibizumabQ: What is
Ranibizumab Q: What is the CAS Number of
Ranibizumab Q: What is the storage condition of
Ranibizumab;Research Grade Ranibizumab(DHD12601);Ranibizumab (anti-VEGF) | | CAS: | 347396-82-1 | | MF: | C11H12N2O2 | | MW: | 204.22518 | | EINECS: | | | Mol File: | 347396-82-1.mol |  |
Use
Ranibizumab is a recombinant, humanized, IgG1 monoclonal antibody fragment
(Fab) that neutralizes all active forms of vascular endothelial growth factor
A (VEGF-A), and it is indicated for the treatment of neovascular age-related
macular degeneration (AMD). It consists of a nonbinding human sequence
and a high-affinity binding epitope (Fab fragment) derived from the mouse. The
full-length RhuMab VEGF (bevacizumab) was launched previously by Genentech
for the treatment of colorectal cancer. Both the antibody fragment and the
full-length antibody bind to and inhibit all active forms of VEGF-A and are
derived from the same mouse monoclonal antibody. However, ranibizumab has
been genetically engineered through a process of selective mutation to increase
its affinity for binding and inhibiting the growth factor.
- Ranibizumab
-
- US $0.00 / kg
- 2024-05-24
- CAS:347396-82-1
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 10000kg
- Ranibizumab
-
- US $0.00-0.00 / mg
- 2021-09-16
- CAS:347396-82-1
- Min. Order: 5mg
- Purity: 99%
- Supply Ability: 100KG
- Ranibizumab
-
- US $10.00 / KG
- 2021-08-31
- CAS:347396-82-1
- Min. Order: 1KG
- Purity: 99.99%
- Supply Ability: 20 tons/month
|
|
347396-82-1
Recommend Suppliers |
|